VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published on July 3rd; they will resume distribution
on Monday, July 6th.
|
|
| juLY
1, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
CONTINUING NEXT WEEK! |
Due
to the 4th of July holiday, we will have
our next CEO Q&A next week with Jehee
Suh, CEO, Inocras - check out our previous
Q&As here.
|
|
|
|
Our
Newest Location: Mispro San
Diego!
Reserve
your space today in our Sorrento
Mesa
Contract Vivarium |
|
Learn More
→ |
|
|
- AAA
Biotech: Expands Global Authorized Distributor
Network to Improve Access to High-Quality
Research Reagents More
- Artelo
Biosciences: New Data Supporting ART26.12 as
a Potential First-in-Class Therapy for
Chronic Pain Associated With Spinal Cord
Injury More
- Artelo
Biosciences: Presents Evidence for a Common
Lipid-Signaling Link Across Multiple
Potential Indications for Its FABP5
Inhibitor Platform at ICRS 2026 More
- Aspen
Neuroscience: Completion of Cohort 3 and 4
Dosing in Aspiro Phase 1/2a Trial of
Sasineprocel for Parkinson's Disease More
- Contineum
Therapeutics: Publishes Discovery of Potential
Best-in-Class LPAR1 Antagonist PIPE-791 in
Journal of Medicinal Chemistry More
- Inocras
and AimedBio: Partner to Advance Cancer Drug
Discovery and Precision Oncology with Whole
Genome Intelligence More
- Modular
Medical: Delivers Insulin to First Patients on
Pivot Tubeless Insulin Patch Pump More
- SkylineDx:
Merlin CP-GEP Granted FDA Breakthrough
Device Designation, Building on Exclusive
NCCN Recognition in Melanoma Care More
- Tandem
Diabetes Care: Launches t:slim X2 Insulin Pump
Compatibility With Abbott FreeStyle Libre 3
Plus Sensor in Five International Markets More
|
|
 |
|
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Aptose Biosciences: Completion of
Acquisition by Hanmi Pharmaceutical More
- Gossamer Bio: Determination of Conversion
Rate for 7.50% Convertible Senior Secured
First Lien Notes due 2030 and Exercise Price
for Purchase Warrants More
- Pictor Holdings: Secures $7.5 Million Bridge
Round to Accelerate Commercialization of
Targeted Proteomic Platform More
|
|
|
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026 More
- Life Science Cares San Diego Nourishing
Students, Strengthening Community More
- SBP: Parsing the Pathology of Prostate
Cancer More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Halozyme: Appoints David Ramsay as President
Drug Delivery More
- ICYMI: Chutes & Ladders—EMD Serono Taps
in New Commercial Strategy Head More
- ICYMI: Leslie Loveless Offers Her
Perspectives on the Rise in Life Sciences IPO
and Investment Activities in a Recent
PharmaVoice Article More
- OPPORTUNITY: Chief Scientific Officer,
Manassas, VA More
- OPPORTUNITY: Head, Business Development,
Emeryville, CA More
- OPPORTUNITY: Head of Clinical Operations,
Newton, MA More
- Slone Partners: A View from the
Trenches - Biotech Series A in 2026 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|